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Introduction
Although the prolapsing, glistening, cauliflower-like
lesions of intraurethral condyloma acuminata appear
innocuous, they are commonly associated with ure-
thral irritation and infection, resulting in total urinary
tract obstruction and fistula formation.1 Treatment 
of urethral warts aims to induce a wart-free state and
reduce the amount of infectious virus present. Medi-
cal treatment with podofilox 0.5% solution or gel,2
imiquimod 5% cream, trichloracetic acid or bichlor-
acetic acid in 80% or 90% solution, and cryotherapy
with liquid nitrogen and solid carbon dioxide are use-
ful. Surgical treatment with laser therapy with both
carbon dioxide and Nd:YAG lasers has been successful
in treating condyloma.3 However, intraurethral warts
may be difficult to treat. In our search for an agent
that can eradicate intraurethral condyloma acuminata
rapidly, safely, and effectively, we used 5-fluorouracil
(5-FU) solution intraurethral instillation and got an
excellent outcome.
Case Report
We report a 43-year-old man with the major com-
plaint of difficult micturition and blood dribbling 
from the urethral meatus. He is an HIV carrier and 
has been on Ritonavir, Saquinavir-gel, and Zidovudine 
3-combined therapy for more than 10 years. Previously,
he had also received diathermy for perianal warts.
Physical examination showed cauliflower lesions over
the urethral meatus and at the base of the frenulum.
Urinalysis disclosed pyuria and microscopic hematuria.
Diathermy was performed for external genital warts.
Cystourethroscopy on the following day showed exten-
sive wart lesions extending from the penile urethra to
the bladder neck. No vesical lesions were found
(Figure 1A). Biopsy of the lesions revealed epithelial
hyperplasia manifestations of hyperkeratosis, paraker-
atosis, acanthosis and papillomatosis, compatible with
condyloma acuminata. 5-FU solution (500 mg in nor-
mal saline 50 mL) urethral instillation with massage at
the ventral side of the penile shaft for 20 minutes was
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given once a week for 7 doses. Management was then
prescribed once a month until the lesion became 
invisible under urethroscopy. Urinalysis results were
normal. The condyloma acuminata of the urethra
shrank under cystourethroscopy every week. However,
recurrent perianal and rectal warts were found. The
patient was admitted to the colorectal surgery ward
for electrocauterization. 5-FU solution intraurethral
instillation was hold. However, cystourethroscopy
revealed recurrent urethral warts and urethritis 3
months later. After 18 doses of 5-FU solution intra-
urethral instillation, no visible wart lesions were noted
in the urethra by cystourethroscopy (Figure 1B). He
has been asymptomatic with no voiding difficulty for
more than 1 year.
Discussion
Genital warts or condylomata acuminata is a sexually
transmitted disease caused by the human papilloma
virus (HPV). It usually affects the skin or external
urethral meatus, and less commonly affects the proxi-
mal penile urethra. They are associated with dysuria,
urethral bleeding, and infection.4 Those affecting the
anterior urethra are usually single and rarely multiple.
Extensive urethral warts presenting as voiding dys-
function are less common. Immunosuppressed and
immunocompromised individuals are at risk of devel-
oping extensive urethral condyloma.5 With better
medicine, quality of life and survival in these patient
groups, urethral condyloma is encountered more often
in urologic practice.
Papillomaviruses are small DNA viruses measur-
ing 50 nm in diameter causing squamous epithelial
cell proliferation. There are over 60 types of HPV 
recognized so far, and probably more will be recorded
in the future. Anogenital warts are caused by muco-
sotropic HPV, type 6 and 11. For anogenital HPV
infection, considerable data indicate a strong asso-
ciation between certain oncogenic “high risk” mucoso-
tropic HPV types and the risk of developing epithelial
and genital cancers. 5-FU is a widely used chemother-
apeutic agent that inhibits cancer cell growth and ini-
tiates apoptosis by targeting thymidylate synthase 
and by direct incorporation of 5-FU metabolites 
into DNA and RNA. 5-FU cream1 and gel injection6
had good therapeutic response to genital wart. The
patient had successful eradication of intraurethral
condyloma acuminata by the intraurethral instillation
of 18 doses of 5-FU 500 mg. However, complications
such as scrotal irritation or meatitis are not avoidable.
Cystourethroscopic examination may be delayed until
distal lesions have been eradicated. This minimally
invasive method is safe, convenient, inexpensive, pain-
less, and effective.
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Figure 1. (A) Before and (B) after therapy with 5-FU urethral instillation; warty lesions have shrunk.
